Résumé : Characterized by developmentally inappropriate levels of inattention, hyperactivity and impulsivity, Attention-Deficit HyperactivityDisorder (ADHD) is the most prevalent neurodevelopmental disorder, posing a significant public health concern. Currently,methylphenidate (MPH) is the primary pharmacological treatment of choice but associated with notable side effects promptingthe search for alternative therapies. Pycnogenol®, an extract rich in polyphenols derived from maritime pine, renowned for itsantioxidant, immunomodulatory, and anti-inflammatory properties, emerges as a promising alternative. Limited studies in ADHDconsistently reveal that Pycnogenol® treatment for 4 to 10 weeks improves attention span while reducing impulsive and hyperactivebehaviors. Its potential to rebalance neurotransmitter levels and positively influence gut microbiota, supposed to be altered in ADHD,coupled with minimal side effects, suggests Pycnogenol® as a viable natural alternative to MPH. This study aims to review existingscientific literature on Pycnogenol® administration in ADHD, addressing etiology, treatment, hypothesized of mechanisms of actionand the initial findings on its effects on ADHD symptomatology and cognitive function. While the potential of Pycnogenol® as atherapeutic alternative is encouraging, further investigations are essential to fully elucidate its mechanisms and efficacy. These findingsunderscore the importance of exploring innovative treatments for ADHD and highlight the challenges in objective assessment andtreatment development.